Forging the future of vaccine technology
National Geographic highlights the companies — including Merck — exploring potential breakthroughs in continuous vaccine production
August 18, 2021
Meeting the global need for vaccinations means innovating how vaccines are produced, as National Geographic details in a recent article about the work being done to revolutionize processes.
“There’s no one standardized method of making a vaccine,” Tarit Mukhopadhyay, Merck’s head of vaccine process research & development, tells the magazine. The most common method currently in use involves producing the necessary materials in giant vats, one batch at a time — which can be incredibly time-consuming.
But recent innovations — like utilizing long, narrow tubes as incubation devices — have the potential to streamline the process and revolutionize vaccine production.
“I think we're really at a turning point. Both in terms of vaccine discovery, but also vaccine manufacturing itself.”
Tarit Mukhopadhyay
Head of vaccine process R&DTo read the full story, head to National Geographic (email sign-up required).
